These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
587 related articles for article (PubMed ID: 22021706)
21. High glucose induces toll-like receptor expression in human monocytes: mechanism of activation. Dasu MR; Devaraj S; Zhao L; Hwang DH; Jialal I Diabetes; 2008 Nov; 57(11):3090-8. PubMed ID: 18650365 [TBL] [Abstract][Full Text] [Related]
22. The Role of TLR4 on PGC-1 Yuan S; Liu X; Zhu X; Qu Z; Gong Z; Li J; Xiao L; Yang Y; Liu H; Sun L; Liu F Oxid Med Cell Longev; 2018; 2018():6296802. PubMed ID: 29861832 [TBL] [Abstract][Full Text] [Related]
23. 1,25(OH) Liu P; Li F; Xu X; Li S; Dong X; Chen L; Bai B; Wang Y; Qiu M; Dong Y Exp Mol Pathol; 2020 Jun; 114():104434. PubMed ID: 32240615 [TBL] [Abstract][Full Text] [Related]
24. Increased toll-like receptor (TLR) activation and TLR ligands in recently diagnosed type 2 diabetic subjects. Dasu MR; Devaraj S; Park S; Jialal I Diabetes Care; 2010 Apr; 33(4):861-8. PubMed ID: 20067962 [TBL] [Abstract][Full Text] [Related]
25. Exacerbation of diabetic nephropathy by hyperlipidaemia is mediated by Toll-like receptor 4 in mice. Kuwabara T; Mori K; Mukoyama M; Kasahara M; Yokoi H; Saito Y; Ogawa Y; Imamaki H; Kawanishi T; Ishii A; Koga K; Mori KP; Kato Y; Sugawara A; Nakao K Diabetologia; 2012 Aug; 55(8):2256-66. PubMed ID: 22610400 [TBL] [Abstract][Full Text] [Related]
26. Toll-Like Receptor 4 Activation Contributes to Diabetic Bladder Dysfunction in a Murine Model of Type 1 Diabetes. Szasz T; Wenceslau CF; Burgess B; Nunes KP; Webb RC Diabetes; 2016 Dec; 65(12):3754-3764. PubMed ID: 27650857 [TBL] [Abstract][Full Text] [Related]
27. NQO1 alleviates renal fibrosis by inhibiting the TLR4/NF-κB and TGF-β/Smad signaling pathways in diabetic nephropathy. Qiu D; Song S; Chen N; Bian Y; Yuan C; Zhang W; Duan H; Shi Y Cell Signal; 2023 Aug; 108():110712. PubMed ID: 37196773 [TBL] [Abstract][Full Text] [Related]
28. HMGN1 down-regulation in the diabetic kidney attenuates tubular cells injury and protects against renal inflammation via suppressing MCP-1 and KIM-1 expression through TLR4. Yu J; Da J; Yu F; Yuan J; Zha Y J Endocrinol Invest; 2024 Apr; 47(4):1015-1027. PubMed ID: 38409569 [TBL] [Abstract][Full Text] [Related]
29. Pharmacological inhibition of MyD88 suppresses inflammation in tubular epithelial cells and prevents diabetic nephropathy in experimental mice. Zhang QY; Xu SJ; Qian JC; Yang LB; Chen PQ; Wang Y; Hu X; Zhang YL; Luo W; Liang G Acta Pharmacol Sin; 2022 Feb; 43(2):354-366. PubMed ID: 34552217 [TBL] [Abstract][Full Text] [Related]
30. High-mobility group box-1 mediates toll-like receptor 4-dependent angiogenesis. Lin Q; Yang XP; Fang D; Ren X; Zhou H; Fang J; Liu X; Zhou S; Wen F; Yao X; Wang JM; Su SB Arterioscler Thromb Vasc Biol; 2011 May; 31(5):1024-32. PubMed ID: 21372296 [TBL] [Abstract][Full Text] [Related]
31. Knockout of toll-like receptor-2 attenuates both the proinflammatory state of diabetes and incipient diabetic nephropathy. Devaraj S; Tobias P; Kasinath BS; Ramsamooj R; Afify A; Jialal I Arterioscler Thromb Vasc Biol; 2011 Aug; 31(8):1796-804. PubMed ID: 21617141 [TBL] [Abstract][Full Text] [Related]
32. AGE-LDL activates Toll like receptor 4 pathway and promotes inflammatory cytokines production in renal tubular epithelial cells. Cheng A; Dong Y; Zhu F; Liu Y; Hou FF; Nie J Int J Biol Sci; 2013; 9(1):94-107. PubMed ID: 23355795 [TBL] [Abstract][Full Text] [Related]
33. Lysophosphatidic acid receptor 1 inhibitor, AM095, attenuates diabetic nephropathy in mice by downregulation of TLR4/NF-κB signaling and NADPH oxidase. Lee JH; Sarker MK; Choi H; Shin D; Kim D; Jun HS Biochim Biophys Acta Mol Basis Dis; 2019 Jun; 1865(6):1332-1340. PubMed ID: 30763641 [TBL] [Abstract][Full Text] [Related]
34. Toll-like receptor 4 contributes to uterine activation by upregulating pro-inflammatory cytokine and CAP expression via the NF-κB/P38MAPK signaling pathway during pregnancy. Chen Z; Liu Q; Zhu Z; Xiang F; Wu R; Kang X J Cell Physiol; 2020 Jan; 235(1):513-525. PubMed ID: 31236964 [TBL] [Abstract][Full Text] [Related]
35. Bupleurum polysaccharides ameliorated renal injury in diabetic mice associated with suppression of HMGB1-TLR4 signaling. Liu ZZ; Weng HB; Zhang LJ; Pan LY; Sun W; Chen HX; Chen MY; Zeng T; Zhang YY; Chen DF; Li H Chin J Nat Med; 2019 Sep; 17(9):641-649. PubMed ID: 31526499 [TBL] [Abstract][Full Text] [Related]
36. RUNX3 alleviates mitochondrial dysfunction and tubular damage by inhibiting TLR4/NF-κB signalling pathway in diabetic kidney disease. Xiao L; Ye G Nephrology (Carlton); 2024 Aug; 29(8):470-481. PubMed ID: 38735649 [TBL] [Abstract][Full Text] [Related]
37. Up-Regulation of HMGB1 Exacerbates Renal Ischemia-Reperfusion Injury by Stimulating Inflammatory and Immune Responses through the TLR4 Signaling Pathway in Mice. Chen CB; Liu LS; Zhou J; Wang XP; Han M; Jiao XY; He XS; Yuan XP Cell Physiol Biochem; 2017; 41(6):2447-2460. PubMed ID: 28472797 [TBL] [Abstract][Full Text] [Related]
38. LncRNA SNHG16 regulates RAS and NF-κB pathway-mediated NLRP3 inflammasome activation to aggravate diabetes nephropathy through stabilizing TLR4. Liu Y; Zhang M; Zhong H; Xie N; Wang Y; Ding S; Su X Acta Diabetol; 2023 Apr; 60(4):563-577. PubMed ID: 36658449 [TBL] [Abstract][Full Text] [Related]
39. The role of TLR2 and 4-mediated inflammatory pathways in endothelial cells exposed to high glucose. Mudaliar H; Pollock C; Ma J; Wu H; Chadban S; Panchapakesan U PLoS One; 2014; 9(10):e108844. PubMed ID: 25303153 [TBL] [Abstract][Full Text] [Related]
40. Effects of total glucosides of paeony on immune regulatory toll-like receptors TLR2 and 4 in the kidney from diabetic rats. Xu XX; Qi XM; Zhang W; Zhang CQ; Wu XX; Wu YG; Wang K; Shen JJ Phytomedicine; 2014 May; 21(6):815-23. PubMed ID: 24462407 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]